Literature DB >> 21220417

Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.

Xin Huang1, Alireza R Rezaie, George J Broze, Steven T Olson.   

Abstract

Protein Z-dependent protease inhibitor (ZPI) is a recently identified member of the serpin superfamily that functions as a cofactor-dependent regulator of blood coagulation factors Xa and XIa. Here we provide evidence that, in addition to the established cofactors, protein Z, lipid, and calcium, heparin is an important cofactor of ZPI anticoagulant function. Heparin produced 20-100-fold accelerations of ZPI reactions with factor Xa and factor XIa to yield second order rate constants approaching the physiologically significant diffusion limit (k(a) = 10(6) to 10(7) M(-1) s(-1)). The dependence of heparin accelerating effects on heparin concentration was bell-shaped for ZPI reactions with both factors Xa and XIa, consistent with a template-bridging mechanism of heparin rate enhancement. Maximal accelerations of ZPI-factor Xa reactions required calcium, which augmented the heparin acceleration by relieving Gla domain inhibition as previously shown for heparin bridging of the antithrombin-factor Xa reaction. Heparin acceleration of both ZPI-protease reactions was optimal at heparin concentrations and heparin chain lengths comparable with those that produce physiologically significant rate enhancements of other serpin-protease reactions. Protein Z binding to ZPI minimally affected heparin rate enhancements, indicating that heparin binds to a distinct site on ZPI and activates ZPI in its physiologically relevant complex with protein Z. Taken together, these results suggest that whereas protein Z, lipid, and calcium cofactors promote ZPI inhibition of membrane-associated factor Xa, heparin activates ZPI to inhibit free factor Xa as well as factor XIa and therefore may play a physiologically and pharmacologically important role in ZPI anticoagulant function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220417      PMCID: PMC3058988          DOI: 10.1074/jbc.M110.188375

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Calculation of protein extinction coefficients from amino acid sequence data.

Authors:  S C Gill; P H von Hippel
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

2.  Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

Authors:  S T Olson; I Björk; J D Shore
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

3.  Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects.

Authors:  S T Olson; I Björk
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

4.  Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models.

Authors:  S T Olson; H R Halvorson; I Björk
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

5.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.

Authors:  S T Olson; I Björk; R Sheffer; P A Craig; J D Shore; J Choay
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

6.  Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sites.

Authors:  M Kusche; G Torri; B Casu; U Lindahl
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

7.  Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.

Authors:  R E Hurst; M C Poon; M J Griffith
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

8.  Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.

Authors:  V J Streusand; I Björk; P G Gettins; M Petitou; S T Olson
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

9.  Heparan sulphate with no affinity for antithrombin III and the control of haemostasis.

Authors:  M F Scully; V Ellis; V V Kakkar
Journal:  FEBS Lett       Date:  1988-12-05       Impact factor: 4.124

10.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

Authors:  J A Marcum; D H Atha; L M Fritze; P Nawroth; D Stern; R D Rosenberg
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more
  19 in total

1.  Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).

Authors:  Xin Huang; Baoxin Liu; Yidong Wei; Ryan Beyea; Han Yan; Steven T Olson
Journal:  J Biol Chem       Date:  2017-07-17       Impact factor: 5.157

2.  Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity.

Authors:  Eric Calvo; Daniella M Mizurini; Anderson Sá-Nunes; José M C Ribeiro; John F Andersen; Ben J Mans; Robson Q Monteiro; Michail Kotsyfakis; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

3.  Factor XI anion-binding sites are required for productive interactions with polyphosphate.

Authors:  Y Geng; I M Verhamme; S A Smith; Q Cheng; M Sun; J P Sheehan; J H Morrissey; D Gailani
Journal:  J Thromb Haemost       Date:  2013-11       Impact factor: 5.824

Review 4.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

5.  Association of the R67X and W303X non-sense polymorphisms in the protein Z-dependent protease inhibitor gene with idiopathic recurrent miscarriage.

Authors:  F S AlShaikh; R R Finan; A W Almawi; F E Mustafa; W Y Almawi
Journal:  Mol Hum Reprod       Date:  2011-10-27       Impact factor: 4.025

6.  Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.

Authors:  Likui Yang; Qiulan Ding; Xin Huang; Steven T Olson; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-05-02       Impact factor: 3.162

7.  Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239.

Authors:  Xin Huang; Jian Zhou; Aiwu Zhou; Steven T Olson
Journal:  J Biol Chem       Date:  2015-02-20       Impact factor: 5.157

8.  A plasmin-activatable thrombin inhibitor reduces experimental thrombosis and assists experimental thrombolysis in murine models.

Authors:  W P Sheffield; L J Eltringham-Smith; S Gataiance; V Bhakta
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

9.  Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12).

Authors:  David Ulbricht; Kathrin Oertwig; Kristin Arnsburg; Anja Saalbach; Jan Pippel; Norbert Sträter; John T Heiker
Journal:  J Biol Chem       Date:  2016-12-09       Impact factor: 5.157

10.  Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism.

Authors:  Hudie Wei; Haiyan Cai; Jiawei Wu; Zhenquan Wei; Fei Zhang; Xin Huang; Lina Ma; Lingling Feng; Ruoxi Zhang; Yunjie Wang; Hermann Ragg; Ying Zheng; Aiwu Zhou
Journal:  J Biol Chem       Date:  2016-09-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.